GT
SPNC

Glenmede Trust’s Spectranetics Corp SPNC Stock Holding History

Glenmede Trust’s Portfolio SPNC Stock Details SPNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33
Closed – – 2820
2016
Q4 		$0 Sell
33
-15
-31% -$353 ﹤0.01% 2719
2016
Q3 		$1K Buy
+48
New +$1.12K ﹤0.01% 2540
2015
Q2 		– Sell
-366
Closed -$12K – 2842
2015
Q1 		$12K Hold
366
– – ﹤0.01% 2099
2014
Q4 		$12K Buy
366
+173
+90% +$5.39K ﹤0.01% 2176
2014
Q3 		$5K Hold
193
– – ﹤0.01% 2251
2014
Q2 		$4K Sell
193
-86
-31% -$2K ﹤0.01% 2197
2014
Q1 		$8K Sell
279
-23
-8% -$630 ﹤0.01% 2089
2013
Q4 		$7K Hold
302
– – ﹤0.01% 2072
2013
Q3 		$5K Sell
302
-1,775
-85% -$31K ﹤0.01% 2061
2013
Q2 		$38K Buy
+2,077
New +$39.3K ﹤0.01% 1586

Other funds holding SPNC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Glenmede Trust's SPNC Position: Q1 2017 in Review

Glenmede Trust sold out of Spectranetics Corp (SPNC) in Q1 2017, closing a stake of 33 shares.

Glenmede Trust first reported a position in SPNC in Q2 2013 and held it in 10 quarters. The position peaked at $38K in Q2 2013. 146 funds tracked by Wall St. Rank hold SPNC as of Q1 2017.

  • Glenmede Trust reported no remaining Spectranetics Corp position as of Q1 2017 after selling out during the quarter.
  • Glenmede Trust sold 33 Spectranetics Corp shares in Q1 2017.
  • Glenmede Trust first reported a position in Spectranetics Corp in Q2 2013 and held it in 10 quarters.
  • Glenmede Trust's Spectranetics Corp position peaked at $38K in Q2 2013.
  • 146 funds tracked by Wall St. Rank held Spectranetics Corp as of Q1 2017.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.